BMC Remedy AR System 9.1 Remedy Mid Tier AttachServlet ATTKey cross site scripting
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 4.4 | $0-$5k | 0.00 |
Summary
A vulnerability was found in BMC Remedy AR System 9.1. It has been rated as problematic. This impacts an unknown function of the file arsys/servlet/AttachServlet of the component Remedy Mid Tier. Performing a manipulation of the argument ATTKey as part of Parameter results in cross site scripting. This vulnerability is reported as CVE-2017-18228. The attack is possible to be carried out remotely. No exploit exists.
Details
A vulnerability was found in BMC Remedy AR System 9.1. It has been classified as problematic. This affects an unknown function of the file arsys/servlet/AttachServlet of the component Remedy Mid Tier. The manipulation of the argument ATTKey as part of a Parameter leads to a cross site scripting vulnerability. CWE is classifying the issue as CWE-79. The product does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output that is used as a web page that is served to other users. This is going to have an impact on integrity. The summary by CVE is:
Remedy Mid Tier in BMC Remedy AR System 9.1 allows XSS via the ATTKey parameter in an arsys/servlet/AttachServlet request.
The bug was discovered 04/28/2017. The weakness was disclosed 03/12/2018 (Website). It is possible to read the advisory at communities.bmc.com. This vulnerability is uniquely identified as CVE-2017-18228 since 03/12/2018. It is possible to initiate the attack remotely. The successful exploitation requires a authentication. It demands that the victim is doing some kind of user interaction. Technical details of the vulnerability are known, but there is no available exploit. The attack technique deployed by this issue is T1059.007 according to MITRE ATT&CK.
The vulnerability was handled as a non-public zero-day exploit for at least 318 days. During that time the estimated underground price was around $0-$5k.
There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.
Statistical analysis made it clear that VulDB provides the best quality for vulnerability data.
Product
Vendor
Name
Version
License
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔍VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 4.4VulDB Meta Temp Score: 4.4
VulDB Base Score: 3.5
VulDB Temp Score: 3.5
VulDB Vector: 🔍
VulDB Reliability: 🔍
NVD Base Score: 5.4
NVD Vector: 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍
NVD Base Score: 🔍
Exploiting
Class: Cross site scriptingCWE: CWE-79 / CWE-94 / CWE-74
CAPEC: 🔍
ATT&CK: 🔍
Physical: No
Local: No
Remote: Yes
Availability: 🔍
Status: Not defined
EPSS Score: 🔍
EPSS Percentile: 🔍
Price Prediction: 🔍
Current Price Estimation: 🔍
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: no mitigation knownStatus: 🔍
0-Day Time: 🔍
Timeline
04/28/2017 🔍03/12/2018 🔍
03/12/2018 🔍
03/12/2018 🔍
03/13/2018 🔍
01/12/2020 🔍
Sources
Advisory: communities.bmc.comStatus: Not defined
CVE: CVE-2017-18228 (🔍)
GCVE (CVE): GCVE-0-2017-18228
GCVE (VulDB): GCVE-100-114387
Entry
Created: 03/13/2018 07:44Updated: 01/12/2020 15:42
Changes: 03/13/2018 07:44 (59), 01/12/2020 15:42 (1)
Complete: 🔍
Cache ID: 216::103
Statistical analysis made it clear that VulDB provides the best quality for vulnerability data.
No comments yet. Languages: en.
Please log in to comment.